Ailsa L Hart
Overview
Explore the profile of Ailsa L Hart including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
117
Citations
3771
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Noor N, Radford S, Choodari-Oskooei B, Gordon M, Hart A, Hepburn T, et al.
Nat Rev Gastroenterol Hepatol
. 2025 Mar;
PMID: 40045038
No abstract available.
2.
Al Bakir I, Curtius K, Cresswell G, Grant H, Nasreddin N, Smith K, et al.
Gut
. 2025 Jan;
PMID: 39880602
Background: The risk of developing advanced neoplasia (AN; colorectal cancer and/or high-grade dysplasia) in ulcerative colitis (UC) patients with a low-grade dysplasia (LGD) lesion is variable and difficult to predict....
3.
Munster L, Hanna L, Hart A, Tozer P, Buskens C, van der Bilt J
J Crohns Colitis
. 2025 Jan;
19(1).
PMID: 39777453
Background: The aim of this Delphi study was to reach consensus on a new clinical decision tool to help identify or exclude Crohn's disease (CD) in patients with perianal fistula(s)...
4.
Anand E, Devi J, Joshi S, Antoniou A, Doering M, Stoker J, et al.
BMJ Open
. 2024 Nov;
14(11):e087919.
PMID: 39557555
Introduction: Perianal fistulising Crohn's disease (pfCD) is a distinct and debilitating phenotype seen in around one-third of patients with CD. Clinical trials in pfCD are increasingly using magnetic resonance imaging...
5.
Al Bakir I, Curtius K, Cresswell G, Grant H, Nasreddin N, Smith K, et al.
medRxiv
. 2024 Jul;
PMID: 39040198
Patients with inflammatory bowel disease (IBD) are at increased risk of colorectal cancer (CRC), and this risk increases dramatically in those who develop low-grade dysplasia (LGD). However, there is currently...
6.
Lamb C, Titterton C, Banerjee R, Gomberg A, Rubin D, Hart A
Lancet
. 2024 May;
404(10451):414-417.
PMID: 38768627
No abstract available.
7.
Moulton C, Young A, Hart A
Clin Gastroenterol Hepatol
. 2024 May;
22(11):2349-2350.
PMID: 38729398
No abstract available.
8.
Wyatt N, Watson H, Anderson C, Kennedy N, Raine T, Ahmad T, et al.
BMJ Open
. 2024 Apr;
14(4):e073639.
PMID: 38631839
Introduction: Characterised by chronic inflammation of the gastrointestinal tract, inflammatory bowel disease (IBD) symptoms including diarrhoea, abdominal pain and fatigue can significantly impact patient's quality of life. Therapeutic developments in...
9.
Mullish B, Merrick B, Quraishi M, Bak A, Green C, Moore D, et al.
Gut
. 2024 Apr;
73(7):1052-1075.
PMID: 38609165
The first British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS)-endorsed faecal microbiota transplant (FMT) guidelines were published in 2018. Over the past 5 years, there has been considerable...
10.
Wijnands A, Penning de Vries B, Lutgens M, Bakhshi Z, Al Bakir I, Beaugerie L, et al.
Clin Gastroenterol Hepatol
. 2024 Mar;
22(8):1697-1708.
PMID: 38431223
Background & Aims: Colonoscopic surveillance is recommended in patients with colonic inflammatory bowel disease (IBD) given their increased risk of colorectal cancer (CRC). We aimed to develop and validate a...